The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.

A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.

Zhitong FinanceApr 25 23:38 ET

Prelude to increased tariffs? The Trump administration has initiated a Section 232 investigation into pharmaceuticals and Semiconductors.

① The USA government disclosed on Monday that it has launched an investigation into the impact of imported Pharmaceuticals and Semiconductors on National Security; ② This is widely seen as a prelude to imposing tariffs on prescription drugs and Semiconductors, and it could further escalate the trade war initiated by the USA.

cls.cnApr 14 20:14 ET

Inovio Pharmaceuticals Inc. Stock Advances 9.9%, Outperforms Competitors

Dow JonesApr 14 16:33 ET

INOVIO to Present at Upcoming Scientific Conferences

PR NewswireApr 9 08:05 ET

Inovio Pharmaceuticals Inc. Stock Rallies 10.7%, Outperforms Competitors

Dow JonesApr 2 16:32 ET

Sector Update: Health Care Stocks Mixed in Afternoon Trading

MT NewswiresMar 31 14:08 ET